Clinical trial / 2002
Wheat grass juice was associated with significant reductions in disease activity and rectal bleeding in active distal ulcerative colitis.
In a randomized, double-blind, placebo-controlled trial, 23 patients with active distal ulcerative colitis were allocated to receive either 100 cc of wheat grass juice or matching placebo daily for 1 month. Twenty-one patients completed the study, with full information available for 19. Treatment with wheat grass juice was associated with significant reductions in the overall disease activity index (P=0.031) and severity of rectal bleeding (P=0.025). No serious side effects were found.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 23 patients diagnosed with active distal ulcerative colitis in Israel
- What was measured
- Disease activity index (including rectal bleeding, bowel movements, sigmoidoscopy, global assessment)
THE PAPER
Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial.
Ben-Arye E, Goldin E, Wengrower D, Stamper A, Kohn R, Berry E. Scand J Gastroenterol, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.